FIELD: pharmaceutics.
SUBSTANCE: the present innovation deals with application of nicergolin as the preparation for treating acute obstruction of the upper urinary tract and preventing renal purulent-inflammatory processes. The above-mentioned preparation is highly efficient in treating acute obstruction of the upper urinary tract and preventing renal purulent-inflammatory processes.
EFFECT: higher efficiency of therapy and prophylaxis.
2 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ACUTE RENAL COLIC IN CHILDREN | 2022 |
|
RU2799833C1 |
| METHOD FOR TREATING THE CASES OF UROLITHIASIS | 1999 |
|
RU2143879C1 |
| METHOD OF ASSESSING RENAL PARENCHYMA REMODELLING PROCESS AFTER RESOLUTION OF OBSTRUCTION IN UROLITHIASIS | 2019 |
|
RU2735812C1 |
| METHOD FOR DETERMINING THE LENGTH OF LITHOTRIPSY FOLLOWING RESOLUTION OF OBSTRUCTION IN UROLITHIASIS | 2019 |
|
RU2723245C1 |
| METHOD FOR ALLEVIATING RENAL COLIC | 1999 |
|
RU2143878C1 |
| METHOD FOR LITHOKINETIC THERAPY IN URETERAL CALCULI | 2014 |
|
RU2549493C1 |
| OSIPYAN'S PERFORATED URETERAL CATHETER | 2019 |
|
RU2724199C1 |
| PERFORATED URETERAL CATHETER | 2018 |
|
RU2689039C1 |
| METHOD FOR REHABILITATION OF PATIENTS SUFFERING UROLITHIASIS FOLLOWING LITHOTRIPSY | 2012 |
|
RU2492881C1 |
| METHOD FOR PREVENTION OF SEVERE COURSE OF GESTATIONAL PYELONEPHRITIS CAUSED BY VESICOURETERAL REFLUX | 2021 |
|
RU2757585C1 |
